![]() ![]() Icterul neonatal reprezintă un subiect amplu dezbătut de către cercetători încă din a doua jumătate a secolului XVIII, iar primele consemnări ale icterului la nou-născut au fost făcute în Antichitate. Toate cele trei cazuri corespund sindromului Ehlers Danlos tip clasic. Până în prezent, această variantă a mai fost raportată în literatură la doar doi pacienți, acesta fiind al treilea. Testarea genetică a evidențiat substituția c.1780C>T, p.(Arg594*) în gena COL5A1 ce duce la apariția unui codon stop prematur, mutația fiind de clasă 2 (potențial patogenică).Ĭoncluzii. ![]() Pacienta prezenta hiperextensibilitate articulară și tegumentară, piele catifelată cu tendință la echimoze, luxație congenitală de șold cu o intervenție chirurgicală eșuată, talus varus și retard Vom prezenta cazul unei fetițe în vârstă de doi ani care este adusă pentru consult genetic cu suspiciunea de sindrom Ehlers Danlos. În unele tipuri, diagnosticarea rapidă poate însemna salvarea vieții pacientului. Sindromul Ehlers Danlos reprezintă un grup de boli ereditare ale țesutului conjunctiv, cu o prevalență combinată de 1 la 5.000 de cazuri ce au în comun hiperlaxitate articulară și anomalii ale pielii. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8–97.5%) for the performance of reperfusion therapy of all patients with STEMI <12 h and 54.4% (region range 37.1–70.1%) for timely reperfusion. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.5–5.9%). A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0–100%), fibrinolysis (18.8% 0–100%), and no reperfusion therapy (9.0% 0–75%) were performed. Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24 h in 196 centres across 29 countries. The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). Radiofrequency catheter ablation using RMN is effective and safe regardless of the presence or not of a severely reduced LVEF. Non-inducibility was achieved in 56.4% of the patients with LVEF ≤ 35% and in 79.2% of the patients with LVEF >35% (p = 0.023). Overall minor complication rate was 2.04% with spontaneous resolution. The statistical analysis was performed using SPSS software. Testing for inducibility was done by ventricular programmed pacing with up to four extra-stimuli. ![]() Non-inducibility following ablation was assessed in all patients presenting with any type of ventricular arrhythmia other than premature ventricular contractions. Success rate was defi ned by complete elimination of clinical arrhythmia. RMN was done using Niobe ES system and an open-irrigated magnetic ablation catheter. CARTO system was used for 3D electroanatomic mapping. ![]() Patients were divided into two groups, with or without severely reduced LVEF ≤ 35%. All clinical and paraclinical, as well as procedural data were collected. No selection criteria for RMN procedure have been applied. We retrospectively analyzed all the patients (n = 98) which have undergone RMN in our center between 2015-2021. Our aim was to compare success and complication rate in patients with or without severely reduced left ventricular ejection fraction (LVEF). Remote magnetic catheter navigation (RMN) has been developed as a novel way of approach aiming to improve outcome and reduce complication rate, and reduce radiation exposure for both operator and patient. Radiofrequency catheter ablation is an effective treatment option for cardiac arrhythmias including complex and ventricular arrhythmias. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |